Home / Import refusals / N90-0944251-4/166/1

FDA Import Refusal N90-0944251-4/166/1 — CP Pharmaceuticals Limited

CP Pharmaceuticals Limited — FEI 3003369660

The FDA refused shipment N90-0944251-4/166/1 from CP Pharmaceuticals Limited (United Kingdom) on March 23, 2017. The refused product falls under Drugs and Biologics — TAMOXIFEN CITRATE (ANTI-ESTROGEN). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 23, 2017
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
61UCB05 TAMOXIFEN CITRATE (ANTI-ESTROGEN)
Charges
75

Recent inspections

  • 948044 (OAI Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 853032 (VAI Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 724836 (VAI Fri May 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 676852 (OAI Thu Jul 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • 799-4630317-8/11/3 (Mon Aug 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • FP1-0020719-9/171/1 (Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 916-2721761-4/1/1 (Fri Nov 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • FP1-0008186-7/28/1 (Fri Oct 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 315-8159008-5/1/1 (Fri Sep 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources